Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/79223
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAvisar, I.en
dc.contributor.authorMcNab, A.en
dc.contributor.authorDolman, P.en
dc.contributor.authorPatel, B.en
dc.contributor.authordeSousa, J.en
dc.contributor.authorSelva-Nayagam, D.en
dc.contributor.authorMalhotra, R.en
dc.date.issued2013en
dc.identifier.citationOrbit, 2013; 32(4):225-230en
dc.identifier.issn0167-6830en
dc.identifier.issn1744-5108en
dc.identifier.urihttp://hdl.handle.net/2440/79223-
dc.description.abstractPURPOSE: To evaluate the outcomes of endonasal dacryocystorhinostomy (EN-DCR) surgery in patients with sarcoidosis. METHODS: Retrospective chart review of all patients with sarcoidosis undergoing EN-DCR in 6 practices from 1999-2011. RESULTS: We included 18 procedures in 14 patients (8 female, 6 male) who underwent EN-DCR for acquired NLDO secondary to sarcoidosis. The mean age was 53.7 (range 38-82). The presenting symptom in all cases was epiphora. Eight patients (57%) complained of having additional nasal congestion. Surgery was performed using endoscopic powered-type DCR with flaps in 12/18 (67%) and non-endoscopic mechanical EN-DCR in 6/18 (33%). In 15 (83%) cases the lacrimal sac and nasal mucosa appeared abnormally yellowish, crusty, oedematous and friable. Five patients were treated with pre-operative oral steroid and overall 8 patients had oral prednisolone post operatively, 30-60 mg tapered within 10 days-8 weeks. One patient had difficulties in tapering down the oral steroids at 6 months of follow-up. All patients were free of epiphora and patent to syringing, with nasal endoscopy revealing free flow of fluorescein through the ostium at a mean follow-up of 11.3 months (median follow-up 9 months). CONCLUSIONS: All 18 cases of acquired nasolacrimal duct obstruction secondary to sarcoidosis were treated successfully with EN-DCR. An abnormal appearance of the nasal mucosa is an important sign. Nasal congestion is a frequent sign. A successful outcome may not depend on intensive long-term therapy with local or systemic steroids. Mechanical or powered EN-DCR for nasolacrimal duct obstruction secondary to sarcoidosis achieves encouraging medium-term outcomes.en
dc.description.statementofresponsibilityInbal Avisar, Alan A. McNab, Peter J. Dolman, Bhupendra Patel, Jean-Louis deSousa, Dinesh Selva, and Raman Malhotraen
dc.language.isoenen
dc.publisherTaylor & Francis The Netherlandsen
dc.rights© Informa Healthcare USA, Inc.en
dc.subjectDacryocystorhinostomy; endonasal; nasolacrimal duct obstruction; sarcoidosisen
dc.titleEndonasal dacryocystorhinostomy for nasolacrimal duct obstruction in patients with sarcoidosisen
dc.typeJournal articleen
dc.identifier.rmid0020130332en
dc.identifier.doi10.3109/01676830.2013.788670en
dc.identifier.pubid18926-
pubs.library.collectionOpthalmology & Visual Sciences publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidSelva-Nayagam, D. [0000-0002-2169-5417]en
Appears in Collections:Opthalmology & Visual Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.